A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol

Carcinogenesis

Volumn 22, Issue 8, 2001, Pages 1111-1117

  Gusman, Julie ^a   Malonne, Hugues ^a   Atassi, Ghanem ^a,b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CYTOCHROME P450; ESTROGEN; NITRIC OXIDE SYNTHASE; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOALEXIN; PROSTAGLANDIN SYNTHASE; RESVERATROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CHEMOPROPHYLAXIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG METABOLISM; ENZYME INHIBITION; GRAPE; GROWTH INHIBITION; HORMONE ACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; MOLECULAR DYNAMICS; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RAT; REVIEW; SKIN TUMOR; WINE;

EID: 0034909129     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.8.1111     Document Type: Article

References (102)

1. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury
2. Chemical constituents of polygonaceous plants. I. Studies on the components of Ko-jo-kon (Polygonum cuspidatum SIEB et ZUCC)
3. Concentration of phytoalexin resveratrol in wine
4. Phytoalexin production potential of grape berries
5. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes
6. Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells
7. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins
8. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests
9. Inhibition of human LDL oxidation by resveratrol
10. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease
11. Effects of stilbenes on arachidonate metabolism in leukocytes
12. Antiplatelet activity of synthetic and natural resveratrol in red wine
13. An antiplatelet principle of Veratrum formosanum
14. Interaction of transresveratrol with plasma lipoproteins
15. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
16. Paradoxical effects of resveratrol on the two prostaglandin H synthases
17. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function
18. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta
19. Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone
20. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor
21. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells
22. Resveratrol activity on guinea pig isolated trachea from normal and albumin-sensitized animals
23. Antioxidant activity of resveratrol closely correlates with its monoamine oxidase-A inhibitory activity
24. Effect of stilbene derivatives on gastric H+, K(+)-ATPase
25. Kinase inhibitors from Polygonum cuspidatum
26. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis
27. Regulation of the immune response by prostaglandins
28. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells
29. Inhibitory effects of hydroxystilbenes on cyclooxygenase from sheep seminal vesicles
30. Effects of resveratrol on 12-O-tetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin
31. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells
32. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production
33. Effects of resveratrol on the autophosphorylation of phorbol ester-responsive protein kinases. Inhibition of protein kinase d but not protein kinase c isozyme autophosphorylation
34. Cancer chemopreventive activity of resveratrol
35. Direct measurement of NAD(P)H:Quinone reductase from cells cultured in microtiter wells: A screening assay for anticarcinogenic enzyme inducers
36. Resveratrol reverses tumor-promoter-induced inhibition of gap-junctional intercellular communication
37. Cell-cell communication in carcinogenesis
38. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis
39. Increased in situ expression of nitric oxide synthase in human colorectal cancer
40. Nitric oxide synthase activity in human gynecological cancer
41. Suppression of nitric oxide synthase and the down-regulation of the activation of NFκB in macrophages by resveratrol
42. Nuclear factor-κB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice
43. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation
44. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages
45. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells
46. Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages
47. A correlative approach for the identification of antimutagens that demonstrate chemopreventive activity
48. Characterization of effective chemopreventive agents in mammary gland in vitro using an initiation-promotion protocol
49. Evaluation of the antioxidant potential of natural products
50. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor
51. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol
52. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: Implications for prevention of dioxin toxicity
53. Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol
54. Resveratrol is a selective human cytochrome P450 1A1 inhibitor
55. Evaluation of butylated hydroxyanisole, myoinositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo(a)pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice
56. Screening of potential chemopreventive agents using biochemical markers of carcinogenesis
57. Potent inhibitory action of red wine polyphenols on human breast cancer cells
58. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway
59. Isolation, identification, and antioxidant activity of three stilbene glucosides newly extracted from Vitis vinifera cell cultures
60. Effects of resveratrol on the rat brain respiratory chain
61. Resveratrol inhibits copper ion-induced and azo compound-initiated oxidative modification of human low density lipoprotein
62. Resveratrol as a new type of DNA-cleaving agent
63. DNA breakage by resveratrol and Cu(II): Reaction mechanism and bacteriophage inactivation
64. Antioxidative and prooxidative action of stilbene derivatives
65. 3
66. Resveratrol, a remarkable inhibitor of ribonucleotide reductase
67. DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia
68. Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells
69. The effect of red wine and its components on growth and proliferation of human oral squamous carcinoma cells
70. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells
71. In vitro response of human gingival epithelial S-G cells to resveratrol
72. Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblast growth
73. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells
74. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IκB kinase
75. Resveratrol arrests the cell division cycle at S/G2 phase transition
76. Discovery of natural product chemopreventive agents utilizing HL-60 cell differentiation as a model
77. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2
78. Resveratrol induces Fas signalling-independent apoptosis in THP-1 human monocytic leukaemia cells
79. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model
80. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21CIP expression
81. Resveratrol selectively inhibits leukemia cells: A prospective agent for ex vivo bone marrow purging
82. Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials
83. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity
84. Membrane modifications in human erythroleukemia K562 cells during induction of programmed cell death by transforming growth factor β1 or cisplatin
85. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells
86. Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol
87. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells
88. Partial and weak oestrogenicity of the red wine constituent resveratrol: Consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects
89. Resveratrol and red wine consumption
90. Is resveratrol an estrogen agonist in growing rats?
91. Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats
92. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines
93. Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells
94. Grape-derived chemopreventive agent resveratrol decreases prostate-specific antigen (PSA) expression in LNCaP cells by an androgen receptor (AR)-independent mechanism
95. Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants
96. Resveratrol in wine
97. Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats
98. Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4′,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats
99. Plasma and tissue resveratrol concentrations and pharmacological activity
100. Resveratrol is absorbed in the small intestine as resveratrol glucuronide
101. Assessment of resveratrol bioavailability in the perfused small intestine of the rat
102. Modulation by phytochemicals of cytochrome P450-linked enzyme activity